Veracyte VCYT
Veracyte Announces Fourth Quarter and Full-Year 2023 Financial Results
- Form
- 8-K
- Filed
- Period
- Importance
- Major
- Accession
- 0001384101-24-000013
- Document
- 8-K
- Exhibit 99.1
- Press release
- Reports quarterly results (2.02)
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 8071 and related industry codes: the same peer list as the financial tables.
- GRAIL GRAL public float $1.9B, Jun 30, 2025
- BillionToOne BLLN
- CareDx CDNA public float $1.0B, Jun 30, 2025
- Lumexa Imaging Holdings LMRI
- Caris Life Sciences CAI public float $3.9B, Jun 30, 2025
